HK1060697A1 - Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors - Google Patents

Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Info

Publication number
HK1060697A1
HK1060697A1 HK04103692A HK04103692A HK1060697A1 HK 1060697 A1 HK1060697 A1 HK 1060697A1 HK 04103692 A HK04103692 A HK 04103692A HK 04103692 A HK04103692 A HK 04103692A HK 1060697 A1 HK1060697 A1 HK 1060697A1
Authority
HK
Hong Kong
Prior art keywords
combined
serotonin reuptake
reuptake inhibitors
novel uses
ht1a agonists
Prior art date
Application number
HK04103692A
Other languages
English (en)
Inventor
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1060697A1 publication Critical patent/HK1060697A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04103692A 2000-11-14 2004-05-25 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors HK1060697A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124815 2000-11-14
PCT/EP2001/011952 WO2002040024A1 (fr) 2000-11-14 2001-10-16 Utilisations nouvelles d'agonistes 5-ht1a et d'inhibiteurs de recaptage de serotinine combines

Publications (1)

Publication Number Publication Date
HK1060697A1 true HK1060697A1 (en) 2004-08-20

Family

ID=8170369

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103692A HK1060697A1 (en) 2000-11-14 2004-05-25 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors

Country Status (22)

Country Link
US (1) US20040082594A1 (fr)
EP (1) EP1333832B1 (fr)
JP (1) JP2004513924A (fr)
KR (1) KR20030059244A (fr)
CN (1) CN1222291C (fr)
AR (1) AR031335A1 (fr)
AU (2) AU2002215027B2 (fr)
BR (1) BR0115296A (fr)
CA (1) CA2428511C (fr)
CZ (1) CZ302484B6 (fr)
DE (1) DE60131675T2 (fr)
ES (1) ES2296820T3 (fr)
HK (1) HK1060697A1 (fr)
HU (1) HUP0302751A3 (fr)
MX (1) MXPA03004166A (fr)
NO (1) NO20032148D0 (fr)
PL (1) PL204331B1 (fr)
RU (1) RU2288719C2 (fr)
SK (1) SK287337B6 (fr)
UA (1) UA79583C2 (fr)
WO (1) WO2002040024A1 (fr)
ZA (1) ZA200304606B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305739A1 (de) 2003-02-11 2004-08-19 Merck Patent Gmbh Benzofuranderivate
DE602004014190D1 (de) 2003-12-23 2008-07-10 Lundbeck As Valby H 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri
US7893261B2 (en) 2004-03-26 2011-02-22 Baylor University Serotonin reuptake inhibitors
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
WO2006034788A1 (fr) * 2004-09-28 2006-04-06 Merck Patent Gmbh Combinaisons de derives de n-(indolecarbonyl-)piperazine et d'inhibiteurs de la recapture de la serotonine
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
RU2462462C2 (ru) * 2006-08-11 2012-09-27 ДСМ АйПи АССЕТС Б.В. Производные лигустилида для лечения расстройств центральной нервной системы

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
DE19512639A1 (de) * 1995-04-05 1996-10-10 Merck Patent Gmbh Benzonitrile und -fluoride
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
DE19730989A1 (de) * 1997-07-18 1999-01-21 Merck Patent Gmbh Piperazin-Derivate
SK492001A3 (en) * 1998-07-20 2001-08-06 Merck Patent Gmbh Biphenyl derivatives

Also Published As

Publication number Publication date
AU2002215027B2 (en) 2006-10-05
PL360310A1 (en) 2004-09-06
CN1222291C (zh) 2005-10-12
HUP0302751A3 (en) 2007-06-28
CN1474691A (zh) 2004-02-11
SK6382003A3 (en) 2003-11-04
RU2288719C2 (ru) 2006-12-10
AR031335A1 (es) 2003-09-17
DE60131675D1 (de) 2008-01-10
EP1333832A1 (fr) 2003-08-13
NO20032148L (no) 2003-05-13
SK287337B6 (sk) 2010-07-07
MXPA03004166A (es) 2003-09-22
KR20030059244A (ko) 2003-07-07
JP2004513924A (ja) 2004-05-13
CZ302484B6 (cs) 2011-06-08
US20040082594A1 (en) 2004-04-29
UA79583C2 (en) 2007-07-10
ES2296820T3 (es) 2008-05-01
NO20032148D0 (no) 2003-05-13
ZA200304606B (en) 2004-09-13
CA2428511A1 (fr) 2002-05-23
CZ20031433A3 (cs) 2003-09-17
BR0115296A (pt) 2003-09-02
AU1502702A (en) 2002-05-27
DE60131675T2 (de) 2008-11-20
WO2002040024A1 (fr) 2002-05-23
EP1333832B1 (fr) 2007-11-28
HUP0302751A2 (hu) 2003-11-28
PL204331B1 (pl) 2010-01-29
CA2428511C (fr) 2009-12-29

Similar Documents

Publication Publication Date Title
HUP0103408A3 (en) Methods of using and compositions comprising dopamine reuptake inhibitors
PT1749818E (pt) Derivados de fenil-piperidina como inibidores da reabsorção da serotonina
HUP0203586A3 (en) The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist
HUP0300371A3 (en) Tag library compounds, compositions, kits and methods of use
IS6849A (is) Tengd pýrídóindól sem serótonín gerandefni og mótefni
MXPA03006010A (es) Derivados de arilamina sustituida y metodos de uso.
PL364580A1 (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
GB2385524B (en) Compositions and methods of use for extracts of magnoliaceae
GB0025782D0 (en) Use of inhibitors
IL172965A0 (en) The combination of a serotonin reuptake inhibitors and agomelatine
AU2003219914A8 (en) Intranasal administration of mc4-r agonists
PL364821A1 (en) Phenylpiperazines as serotonin reuptake inhibitors
MXPA03000694A (es) Nuevo uso de los inhibidores de lipasa.
AU4231699A (en) Inhibitors of serotonin reuptake
IL162308A0 (en) Aminoindane derivatives as serotonin and norepinephrine uptakeinhibitors
HUP0302751A3 (en) Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
PL351301A1 (en) Novel inhibitors of metaloprotease, methods of obtaining them and pharmacological composition containing such inhibitors
HUP0400504A3 (en) Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors
PL345236A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
EP1028958A4 (fr) Arylpiperazines agissant comme inhibiteurs de la reabsorption de serotonine et comme antagonistes de 5-ht1d alpha
HK1051973A1 (en) Condensation derivatives of thiocolchicine and baccatin and composition thereof.
PL354948A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
SI1146041T1 (en) Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline
AU2002213830A1 (en) The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141016